循環(huán)microRNA對支架內(nèi)再狹窄的預(yù)測作用及曲美他嗪的預(yù)防作用
發(fā)布時間:2021-10-19 03:38
背景與目的藥物洗脫支架(drug-eluting stent, DES)得到廣泛應(yīng)用后,但仍有一定比例的患者發(fā)生支架內(nèi)再狹窄(in-stent restenosis, ISR),在不同時間點識別發(fā)生ISR的高;颊呔哂兄匾呐R床意義。目前能有效預(yù)防ISR的藥物較少。本課題旨在尋找新的可以預(yù)測、篩選ISR患者的方法,同時探討曲美他嗪(trimetazidine, TMZ)預(yù)防ISR的有效性。方法⑴PCI術(shù)前循環(huán)microRNA預(yù)測ISR研究:采用microRNA芯片檢測冠心病患者DES植入術(shù)前血樣,比較30例ISR患者和30例非ISR(NISR)患者術(shù)前循環(huán)血中microRNA的表達差異,定量RT-PCR(qRT-PCR)驗證芯片結(jié)果得到候選microRNA。在另一組患者(ISR患者及NISR患者各178例)中用qRT-PCR檢測每例患者候選microRNA的表達水平,Logistic回歸分析得到與ISR相關(guān)的目的microRNA,數(shù)據(jù)轉(zhuǎn)換建立microRNA積分,ROC法分析該積分對ISR的預(yù)測作用。⑵隨訪期間循環(huán)microRNA篩選ISR研究:采用microRNA芯片檢測復(fù)查造影術(shù)前...
【文章來源】:中國人民解放軍醫(yī)學(xué)院北京市
【文章頁數(shù)】:88 頁
【學(xué)位級別】:博士
【部分圖文】:
A.評分與支架內(nèi)再狹窄發(fā)生率的關(guān)系:ISR的發(fā)生率隨積分的增加呈升高趨勢,模型產(chǎn)生隊列與模型驗證隊列比較無統(tǒng)計學(xué)差異
圖 2 評分對 ISR 預(yù)測的 ROC 曲線。AUC=03 討論本研究通過 Logistic 多因素回歸分年發(fā)生 ISR 相關(guān)的預(yù)測因素,包括年齡化血紅蛋白≥6.3%、多支病變以及彌漫
圖1.支架內(nèi)再狹窄組與非在狹窄microRNA評分microRNA積分(49.18±2.05 vs. 52.10±2.41, P<圖2.ROC曲線顯示microRNA評分對支架內(nèi)再狹異度。AUC=0.8206(95% CI: 0.7155-0.9256, 感度和特異度分別為63.33%和86.67%。3 討論本研究首次發(fā)現(xiàn) ISR 患者與 NISR 患
【參考文獻】:
期刊論文
[1]XS0601 REDUCES THE INCIDENCE OF RESTENOSIS: A PROSPECTIVE STUDY OF 335 PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN CHINA[J]. CHEN Ke-ji, SHI Da-zhuo, XU Hao, Lü Shu-zheng, LI Tian-chang, KE Yuan-nan, ZHANG Min-zhou, LU Xiao-yan, SUN Rui-yuan and YOU Shi-jieXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China Department of Cardiology, Anzhen Hospital, Capital University of Medical Sciences, Beijing 100029, China Department of Cardiology, Tongren Hospital, Capital University of Medical Sciences, Beijing 100730, China Department of Cardiology, China-Japan Friendship Hospital, Beijing 100029, China Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120 , China Clinical Drugs Evaluation Center of Anhui Province, Hefei 241001, China Division of Coronary Heart Disease, Fuwai Hospital, China Academy of Medical Sciences, Beijing 100037, China. Chinese Medical Journal. 2006(01)
本文編號:3444078
【文章來源】:中國人民解放軍醫(yī)學(xué)院北京市
【文章頁數(shù)】:88 頁
【學(xué)位級別】:博士
【部分圖文】:
A.評分與支架內(nèi)再狹窄發(fā)生率的關(guān)系:ISR的發(fā)生率隨積分的增加呈升高趨勢,模型產(chǎn)生隊列與模型驗證隊列比較無統(tǒng)計學(xué)差異
圖 2 評分對 ISR 預(yù)測的 ROC 曲線。AUC=03 討論本研究通過 Logistic 多因素回歸分年發(fā)生 ISR 相關(guān)的預(yù)測因素,包括年齡化血紅蛋白≥6.3%、多支病變以及彌漫
圖1.支架內(nèi)再狹窄組與非在狹窄microRNA評分microRNA積分(49.18±2.05 vs. 52.10±2.41, P<圖2.ROC曲線顯示microRNA評分對支架內(nèi)再狹異度。AUC=0.8206(95% CI: 0.7155-0.9256, 感度和特異度分別為63.33%和86.67%。3 討論本研究首次發(fā)現(xiàn) ISR 患者與 NISR 患
【參考文獻】:
期刊論文
[1]XS0601 REDUCES THE INCIDENCE OF RESTENOSIS: A PROSPECTIVE STUDY OF 335 PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN CHINA[J]. CHEN Ke-ji, SHI Da-zhuo, XU Hao, Lü Shu-zheng, LI Tian-chang, KE Yuan-nan, ZHANG Min-zhou, LU Xiao-yan, SUN Rui-yuan and YOU Shi-jieXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China Department of Cardiology, Anzhen Hospital, Capital University of Medical Sciences, Beijing 100029, China Department of Cardiology, Tongren Hospital, Capital University of Medical Sciences, Beijing 100730, China Department of Cardiology, China-Japan Friendship Hospital, Beijing 100029, China Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120 , China Clinical Drugs Evaluation Center of Anhui Province, Hefei 241001, China Division of Coronary Heart Disease, Fuwai Hospital, China Academy of Medical Sciences, Beijing 100037, China. Chinese Medical Journal. 2006(01)
本文編號:3444078
本文鏈接:http://sikaile.net/yixuelunwen/xxg/3444078.html
最近更新
教材專著